AbbVie / 艾伯维

AbbVie / 艾伯维 appears in 130. 谁才是生物医药行业发展的核心驱动力？兼谈创新药产业链的角色分工 in the discussion of successful drug assets moving across companies and partnerships before becoming commercially important. The source uses this kind of path to show that final product value can depend on multiple transfers, development decisions, and commercialization partnerships.

Connections

• First-In-Class Drug Discovery Role Split - asset ownership and development can change between discovery and launch.
• Global Pharma Commercialization - partner and commercialization layer.
• Clinical Development Capability - development strategy after discovery.